Development of a test to measure the immune response in patients with Covid-19

• Conditions: U07.1; COVID-19, virus identified

• Registration Number: DRKS00021166
• Lead Sponsor: Institut für Medizinische Mikrobiologie und Virologie, Universitätsklinikum Leipzig

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-03-27
• Results First Posted: 2020-08-01
• Study Completion: 2021-12-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 55

Inclusion Criteria

Adults with previous SARS CoV-2 infection

Exclusion Criteria

Pregnancy, individuals unable to provide informed consent

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The study determines if the test identifies persons with previous infection by comparing with a gold standard test

Secondary Outcome Measures

Name	Time	Method
Sensitivity and specificity of the test